A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release. T… ...

Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U.S., the report said.

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

ZWINGENBERG, March 18, 2025 – At today's Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all agenda items ...

China is poised to dominate biotechnology in the 21st century by Emily Clise Tully, opinion contributor - 03/09/25 12:00 PM ET ...

The Swedish biotech behind a groundbreaking Alzheimer’s treatment is in talks with partners for its new technology that allows drugs to cross the notoriously tricky blood-brain barrier.

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets the immune checkpoint B7-H3 for diffuse intrinsic pontine glioma, or ...

Now, biotech company NeOnc has developed a new drug delivery system that just might revolutionize the lives of brain cancer patients.

Scientists Find Way to Deliver Medicines Across Brain's Protective Barrier By Dennis Thompson HealthDay Reporter WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- The blood-brain barrier is a natural ...

Akribion Therapeutics GmbH financed by strong Venture Capital Consortium with pharma expertise BRAIN can receive up to EUR 92.3 million R&D and commercial milestone fees plus additional royalties ...

Ron Renaud, biotech’s serial CEO, is ready for a new assignment — and maybe another deal? With Kailera Therapeutics, the industry veteran turns his focus toward obesity drugs ...